Hyris, subsidiary fully owned by Ulisse Biomed S.p.A., signed a distribution agreement with GrowBIGogh a a company selling technology solutions for hydroponics and farming industries, based in Gilroy & Salinas, CA.

The agreement provides for the distribution of the Hyris System by GrowBIGogh in the United States for testing in private companies, laboratories and clinics, and public entities operating in the Cannabis and Plants Health business.

The US Cannabis market is projected to reach US$42.98bn in 2024 (Source: Statista Market Insights).
The Cannabis market covers products derived from the cannabis plant used for medical or recreational purposes. The market includes Medical, Pharmaceutical, and Recreational Cannabis as well as CBD Products. The Medical and Pharmaceutical Cannabis markets include products used to treat conditions such as chronic pain, mental disorders, and other medical conditions. The Recreational Cannabis and the the CBD Products markets include products used for personal enjoyment or leisure purposes.

GrowBIGogh will distribute in United States, in conjunction with Hyris System, a set of molecular testing kits to support cannabis growers in maximising productivity and minimising inefficiencies. The unique characteristics of Hyris System as smart, portable and easy genetic testing solution, make this proposition viable for a larger set of users.  

"This agreement follows Hyris mission to ease the access to genetic testing for a growing number of users and contexts" says Lorenzo Colombo, CTO at Hyris. "It is a demonstration of the recognised performances of Hyris technological solutions in various business segments and our ability to support key players in their field of activity".